(MENAFN- GlobeNewsWire - Nasdaq) Rising Chronic Disease Burden, Biosimilar Insulin Adoption, and Smart Connected Pen Technologies Drive Sustained Market Expansion. Austin, United States, March 12, ...
The global injection pen market is set to witness a growth rate of 7% in the next 5 years. Rising prevalence of chronic diseases, patient convenience and ease of use, technological advancements, ...
Anavip contains venom-specific F(ab’)2 fragments of immunoglobulin G that bind and neutralize venom toxins. Novo Nordisk announced the availability of Ozempic (semaglutide) injection 1mg as a single ...
A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...
Owen Mumford has released a new injection pen training video. Developed in collaboration with consultant pharmacists and nursing professionals, the video addresses critical steps when clinically ...
The injection pen market represents a revolutionary segment within the medical device industry, fundamentally transforming how patients self-administer medications for chronic conditions. These ...
For people who require insulin therapy, staying on top of multiple daily injections and getting the dosages right can be an overwhelming task. Insulin pens can make diabetes management easier, and ...
(MENAFN- GetNews) Injection Pen Market Size, Share & Trends by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved somatropin pre-filled injection pens for the treatment of children and adults with growth ...
DUBLIN--(BUSINESS WIRE)--The "Diabetes Injection Pens Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030" ...
The U.S. Injection Pen Market has been valued at USD 29.76 Billion in 2025 and is expected to reach USD 60.61 Billion by 2035, growing at an estimated CAGR of 7.35% from 2026 to 2035. The prevalence ...